,
Swiss National Cohort. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population, AIDS, vol.31, pp.427-463, 2017. ,
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies, Lancet HIV, vol.4, pp.349-56, 2017. ,
,
Study Group. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since, AIDS, vol.28, pp.1181-91, 2000. ,
Trends in underlying causes of death in people with HIV from, Lancet, vol.384, pp.241-249, 1999. ,
Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy, HIV Clin Trials, vol.12, pp.333-341, 2011. ,
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study, Neurology, vol.75, pp.2087-96, 2010. ,
The prevalence and incidence of neurocognitive impairment in the HAART era, AIDS, vol.21, pp.1915-1936, 2007. ,
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy, Neurology, vol.73, pp.342-350, 2009. ,
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study, Neurology, vol.86, pp.334-374, 2016. ,
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons, Neurology, vol.80, pp.371-380, 2013. ,
,
Future challenges for clinical care of an ageing population infected with HIV: a modelling study, Lancet Infect Dis, vol.15, pp.810-818, 2015. ,
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder, Neurology, vol.78, pp.485-92, 2012. ,
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study, Clin Infect Dis, vol.60, pp.473-80, 2015. ,
,
Diabetes and cognitive decline in a French cohort of patients infected with HIV-1, Neurology, vol.85, pp.1065-73, 2015. ,
INSIGHT SMART Study Group. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons, Neurology, vol.75, pp.864-73, 2010. ,
,
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study, Clin Infect Dis, vol.59, pp.1787-97, 2014. ,
Increasing incidence of ischemic stroke in patients with HIV infection, Neurology, vol.76, pp.444-50, 2011. ,
Updated research nosology for HIVassociated neurocognitive disorders, Neurology, vol.69, pp.1789-99, 2007. ,
Asymptomatic HIVassociated neurocognitive impairment increases risk for symptomatic decline, Neurology, vol.82, pp.2055-62, 2014. ,
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy, AIDS, vol.25, pp.1747-51, 2011. ,
,
Cognitive disorders in HIV-infected patients: are they HIV-related?, AIDS, vol.27, pp.391-400, 2013. ,
,
, Cognitive Impairment in People with HIV in the European Region Study Group. Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men, J Acquir Immune Defic Syndr, vol.67, pp.120-127, 2014.
,
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men, Neurology, vol.73, pp.1292-1301, 2009. ,
No evidence for accelerated aging-related brain pathology in treated human immunodeficiency virus: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project, Clin Infect Dis, vol.66, pp.1899-909, 2018. ,
The French CONSTANCES population-based cohort: design, inclusion and follow-up, Eur J Epidemiol, vol.30, pp.1317-1345, 2015. ,
Norms for standard neuropsychological tests from the French CONSTANCES cohort, Eur J Neurol, vol.26, pp.786-93, 2019. ,
Effect size for the main cognitive function determinants in a large cross-sectional study, Eur J Neurol, vol.23, pp.1614-1640, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01355388
,
Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy, AIDS, vol.30, pp.1027-1065, 2016. ,
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?, BMC Infect Dis, vol.11, p.356, 2011. ,
Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in French clinical and nonclinical adults, Rev Epidemiol Sante Publique, vol.59, pp.327-367, 2011. ,
Cohort profile update: the GAZEL cohort study, Int J Epidemiol, vol.44, pp.77-77, 2015. ,
Premature age-related comorbidities among HIV-infected persons compared with the general population, Clin Infect Dis, vol.53, pp.1120-1126, 2011. ,
Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the Medical Monitoring Project and the Behavioral Risk Factor Surveillance System, PLoS One, vol.9, p.92842, 2014. ,
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, vol.380, pp.37-43, 2012. ,
International Network for Strategic Initiatives in Global HIV Trials START Study Group. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial, HIV Med, vol.16, issue.1, pp.97-108, 2015. ,
Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen, AIDS, vol.31, pp.1565-71, 2017. ,
,
Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study, Lancet HIV, vol.4, pp.411-433, 2017. ,
Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART, AIDS, vol.28, pp.67-72, 2014. ,
Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection, AIDS, vol.33, pp.55-66, 2019. ,
Gray and white matter abnormalities in treated human immunodeficiency virus disease and their relationship to cognitive function, Clin Infect Dis, vol.65, pp.422-454, 2017. ,